File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.soc.2006.05.003
- Scopus: eid_2-s2.0-33746352806
- PMID: 16882498
- WOS: WOS:000241758000009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Parathyroid Cancer
Title | Parathyroid Cancer |
---|---|
Authors | |
Issue Date | 2006 |
Publisher | WB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/ |
Citation | Surgical Oncology Clinics of North America, 2006, v. 15 n. 3, p. 573-584 How to Cite? |
Abstract | Parathyroid cancer is a rare endocrine tumor and an uncommon cause of HPT. Advances have been made to identify a promising molecular diagnostic marker for the disease. The use of accurate preoperative imaging modalities would undoubtedly facilitate its management by making an accurate preoperative diagnosis by assessing its invasiveness, and by searching for nodal or distant metastases. The effectiveness of the application of intraoperative PTH assay in the management of this rare condition remains to be seen. Radical surgical treatment offers the best chance of cure, but for patients who have refractory unresectable disease or metastases, the availability of more effective targeted medical therapy may palliate the debilitating symptoms of hypercalcemia, reduce its metabolic complications, and potentially improve survival. |
Persistent Identifier | http://hdl.handle.net/10722/192072 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.642 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lang, B | - |
dc.contributor.author | Lo, CY | - |
dc.date.accessioned | 2013-10-17T02:08:13Z | - |
dc.date.available | 2013-10-17T02:08:13Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Surgical Oncology Clinics of North America, 2006, v. 15 n. 3, p. 573-584 | - |
dc.identifier.issn | 1055-3207 | - |
dc.identifier.uri | http://hdl.handle.net/10722/192072 | - |
dc.description.abstract | Parathyroid cancer is a rare endocrine tumor and an uncommon cause of HPT. Advances have been made to identify a promising molecular diagnostic marker for the disease. The use of accurate preoperative imaging modalities would undoubtedly facilitate its management by making an accurate preoperative diagnosis by assessing its invasiveness, and by searching for nodal or distant metastases. The effectiveness of the application of intraoperative PTH assay in the management of this rare condition remains to be seen. Radical surgical treatment offers the best chance of cure, but for patients who have refractory unresectable disease or metastases, the availability of more effective targeted medical therapy may palliate the debilitating symptoms of hypercalcemia, reduce its metabolic complications, and potentially improve survival. | - |
dc.language | eng | - |
dc.publisher | WB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/ | - |
dc.relation.ispartof | Surgical Oncology Clinics of North America | - |
dc.subject.mesh | Parathyroid Hormone - blood | - |
dc.subject.mesh | Parathyroid Neoplasms - complications - diagnosis - surgery | - |
dc.subject.mesh | Parathyroidectomy | - |
dc.subject.mesh | Radiopharmaceuticals - diagnostic use | - |
dc.subject.mesh | Technetium Tc 99m Sestamibi - diagnostic use | - |
dc.title | Parathyroid Cancer | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lang, B: blang@hkucc.hku.hk | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.soc.2006.05.003 | - |
dc.identifier.pmid | 16882498 | - |
dc.identifier.scopus | eid_2-s2.0-33746352806 | - |
dc.identifier.hkuros | 117641 | - |
dc.identifier.volume | 15 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 573 | - |
dc.identifier.epage | 584 | - |
dc.identifier.isi | WOS:000241758000009 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1055-3207 | - |